MedPath

Efficacy of midazolam and dexmedetomidine for attenuating the hormonal stress response to endotracheal intubation in hypertensive adult patients undergoing elective surgery.

Phase 3
Recruiting
Conditions
Anaesthesia
Registration Number
PACTR201909641727181
Lead Sponsor
eman sayed
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

ASA physical status II & III, aged 18–65 years, scheduled for elective surgery, and known to be hypertensive with good control ( blood pressure lower than 140/90), were included in the study.

Exclusion Criteria

Patients were excluded if they have known allergy to any of the study drugs, arterial blood pressure more than 140/90, preoperative arrhythmias, tachycardia (heart rate > 100 beats per minute), bradycardia (heart rate < 50 beats per minute), second- or third-degree atrioventricular block, coronary artery disease, , previous cerebrovascular accident, renal or liver impairment, obesity (body mass index>30), and suspected difficult intubation.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the hemodynamics which includes mean arterial blood pressure (MABP) and heart rate (HR)
Secondary Outcome Measures
NameTimeMethod
biochemical end point through serum cortisol and serum norepinephrine level measurement (reflecting the magnitude of the hormonal stress responses
© Copyright 2025. All Rights Reserved by MedPath